Murrell, D. F. Patsatsi, A. Stavropoulos, P. Baum, S. and Zeeli, T. Kern, J. S. Roussaki-Schulze, A. -V. Sinclair, R. and Bassukas, I. D. Thomas, D. Neale, A. Arora, P. Caux, F. Werth, V. P. Gourlay, S. G. Joly, P. BELIEVE Trial Investigators, Proof of concept for the clinical effects of oral rilzabrutinib, the
first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase
II BELIEVE study, British Journal of Dermatology, (185), 745-755, 2021, Wiley, 0007-0963, 1365-2133